Taken together, our peripheral blood sample based measurement of FOXP3 splice variant levels allow early identification of kidney transplant recipients with declining eGFR, as these are characterized by low FOXP3fl splice variant levels despite comparable pre-transplant levels to recipients with stable eGFR. The gene discussed is FOXP3; the disease is urogenital neoplasm.